Drug Profile
Research programme: anti-cancer therapeutics - Cancer Research UK/The Institute of Cancer Research/Merck KGaA
Latest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Cancer Research UK; The Institute of Cancer Research
- Developer Cancer Research UK; Merck KGaA; The Institute of Cancer Research
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 22 Sep 2023 Early research development in Cancer is still ongoing in Germany and United Kingdom
- 28 Feb 2022 No recent reports of development identified for research development in Cancer in Germany
- 28 Feb 2022 No recent reports of development identified for research development in Cancer in United Kingdom